Click Therapeutics Raises $50M in Series D Funding to Commercialize its Prescription Digital Therapeutics
Click Therapeutics, a developer of AI-based digital therapeutics, raised $50 million in Series D funding from Boehringer Ingelheim, to support the commercialization of its CT-155, an investigational prescription digital therapeutic that … Read more